
Philippines: Further Extension of the Suspension Period Under Department Circular No. 2025-0240 and Its Subsequent Extension, Pertaining to the Implementation of Administrative Order No. 2024-0016 Entitled, “Implementation Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
The Philippine Department of Health (DOH) has issued Department Circular (DC) No. 2025-0574, further extending the suspension of the implementation of Administrative Order (AO) No. 2024-0016, which outlines the revised schedule of fees and charges of the Food and Drug Administration (FDA). The newly released circular continues the temporary halt



